Circulating biomarkers and outcome from a randomised phase II trial of sunitinib vs everolimus for patients with metastatic renal cell carcinoma

  • Martin H. Voss
  • , David Chen
  • , Mahtab Marker
  • , A. Ari Hakimi
  • , Chung Han Lee
  • , James J. Hsieh
  • , Jennifer J. Knox
  • , Maurizio Voi
  • , Robert J. Motzer

Research output: Contribution to journal › Article › peer-review

40 Scopus citations

Fingerprint

Dive into the research topics of 'Circulating biomarkers and outcome from a randomised phase II trial of sunitinib vs everolimus for patients with metastatic renal cell carcinoma'. Together they form a unique fingerprint.

Keyphrases

Pharmacology, Toxicology and Pharmaceutical Science